Literature DB >> 10081610

Characterization of AT2 receptor expression in NIH 3T3 fibroblasts.

F M Heemskerk1, S Zorad, N Xu, S J Gutkind, J M Saavedra.   

Abstract

1. A high expression of angiotensin II receptors and of angiotensin-converting enzyme (ACE) activity was detected in confluent NIH 3T3 fibroblasts. 2. Characterization with selective ligands, dithiothreitol, and GTP gamma S, indicated that only the AT2 subtype was expressed. 3. AT2 receptors and ACE expression were strictly dependent on the cell density and growth phase of the cells, with AT2 receptors being expressed earlier than ACE. In contrast, high expression of AT2 receptors irrespective of their growth state was observed in NIH 3T3 cells lacking contact inhibition upon neoplastic transformation with ras. 4. Our results imply a possible relation of AT2 receptors to cell growth and cell-cell contact.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10081610     DOI: 10.1023/a:1006985329240

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  38 in total

1.  Differential distribution of angiotensin converting enzyme in the anterior and posterior lobe of the rat pituitary.

Authors:  H Y Yang; N H Neff
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

2.  Regulated expression of angiotensin II (AT2) binding sites in R3T3 cells.

Authors:  D T Dudley; R M Summerfelt
Journal:  Regul Pept       Date:  1993-03-19

Review 3.  Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications.

Authors:  V J Dzau; H Sasamura; L Hein
Journal:  J Hypertens Suppl       Date:  1993-04

4.  LIGAND: a computerized analysis of ligand binding data.

Authors:  P J Munson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells.

Authors:  Y Kambayashi; S Bardhan; T Inagami
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

6.  Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.

Authors:  H Harada; M Kitagawa; N Tanaka; H Yamamoto; K Harada; M Ishihara; T Taniguchi
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

7.  Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.

Authors:  A T Chiu; J V Duncia; D E McCall; P C Wong; W A Price; M J Thoolen; D J Carini; A L Johnson; P B Timmermans
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

8.  Multiple growth factors modulate mRNA expression of angiotensin II type-2 receptor in R3T3 cells.

Authors:  T Ichiki; Y Kambayashi; T Inagami
Journal:  Circ Res       Date:  1995-12       Impact factor: 17.367

9.  Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.

Authors:  J L Jainchill; S A Aaronson; G J Todaro
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

10.  The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

Authors:  M Stoll; U M Steckelings; M Paul; S P Bottari; R Metzger; T Unger
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  5 in total

1.  Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-β-activated kinase 1 (TAK1) pathways in mice.

Authors:  Wei-Qiang Tan; Qing-Qing Fang; Xiao Z Shen; Jorge F Giani; Tuantuan V Zhao; Peng Shi; Li-Yun Zhang; Zakir Khan; You Li; Liang Li; Ji-Hua Xu; Ellen A Bernstein; Kenneth E Bernstein
Journal:  Br J Pharmacol       Date:  2018-10-08       Impact factor: 8.739

2.  Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation.

Authors:  Juan Wang; Tao Pang; Roman Hafko; Julius Benicky; Enrique Sanchez-Lemus; Juan M Saavedra
Journal:  Neuropharmacology       Date:  2013-12-04       Impact factor: 5.250

3.  Expression and transport of Angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat.

Authors:  Jaroslav Pavel; Hui Tang; Stephen Brimijoin; Armen Moughamian; Tsuyoshi Nishioku; Julius Benicky; Juan M Saavedra
Journal:  Brain Res       Date:  2008-10-17       Impact factor: 3.252

4.  Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways.

Authors:  Qing-Qing Fang; Xiao-Feng Wang; Wan-Yi Zhao; Shi-Li Ding; Bang-Hui Shi; Ying Xia; Hu Yang; Li-Hong Wu; Cai-Yun Li; Wei-Qiang Tan
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

5.  Pleiotropic Effects of Simvastatin and Losartan in Preclinical Models of Post-Traumatic Elbow Contracture.

Authors:  Michael A David; Alex J Reiter; Chelsey L Dunham; Ryan M Castile; James A Abraham; Leanne E Iannucci; Ishani D Shah; Necat Havlioglu; Aaron M Chamberlain; Spencer P Lake
Journal:  Front Bioeng Biotechnol       Date:  2022-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.